SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) was submitted on November 15, 2021. The document serves as a Block Listing Six Monthly Return covering the period from May 1, 2021, to October 31, 2021. The filing details the status of unallotted securities under two specific employee share schemes: the 2017 Deferred Annual Bonus Plan and the Share Save Plan 2012.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure regarding share scheme inventory and does not contain financial performance data.
Material Changes and Share Scheme Activity
The filing reports the following movements in unallotted securities for the six-month period:
- 2017 Deferred Annual Bonus Plan:
- Opening balance: 35,519 shares.
- Increase in block scheme: 230,000 shares.
- Shares issued/allotted: 0.
- Closing balance: 265,519 shares.
- Share Save Plan 2012:
- Opening balance: 382,466 shares.
- Increase in block scheme: 3,000,000 shares.
- Shares issued/allotted: 313,319 shares.
- Closing balance: 3,069,147 shares.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is limited to the statutory reporting of share scheme balances.
Key Facts for Investor Verification
- Verify the total number of shares reserved for employee compensation plans has increased significantly, particularly under the Share Save Plan 2012.
- Note that no shares were issued from the 2017 Deferred Annual Bonus Plan during this period, resulting in a net increase in the reserve.
- Confirm that this filing does not contain financial results; investors should refer to the most recent Form 20-F or quarterly earnings release for financial performance.